1. Home
  2. BGT vs PRQR Comparison

BGT vs PRQR Comparison

Compare BGT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Floating Rate Income Trust

BGT

BlackRock Floating Rate Income Trust

HOLD

Current Price

$11.35

Market Cap

320.3M

Sector

Finance

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$2.09

Market Cap

250.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGT
PRQR
Founded
2004
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
320.3M
250.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BGT
PRQR
Price
$11.35
$2.09
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.14
AVG Volume (30 Days)
107.2K
591.4K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
10.77%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$18,859,556.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.89
$1.07
52 Week High
$13.42
$3.10

Technical Indicators

Market Signals
Indicator
BGT
PRQR
Relative Strength Index (RSI) 50.09 44.60
Support Level $11.20 $2.15
Resistance Level $11.34 $2.49
Average True Range (ATR) 0.11 0.18
MACD 0.04 0.01
Stochastic Oscillator 93.97 33.91

Price Performance

Historical Comparison
BGT
PRQR

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: